Principal Financial Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.4M | Sell |
|
|||||
|
2025
Q1 | $47M | Sell |
|
|||||
|
2024
Q4 | $47.1M | Sell |
|
|||||
|
2024
Q3 | $67.5M | Buy |
|
|||||
|
2024
Q2 | $54.1M | Buy |
|
|||||
|
2024
Q1 | $60.3M | Sell |
|
|||||
|
2023
Q4 | $48.3M | Sell |
|
|||||
|
2023
Q3 | $35.3M | Sell |
|
|||||
|
2023
Q2 | $34M | Buy |
|
|||||
|
2023
Q1 | $37.2M | Sell |
|
|||||
|
2022
Q4 | $38.8M | Sell |
|
|||||
|
2022
Q3 | $28.2M | Buy |
|
|||||
|
2022
Q2 | $30.8M | Buy |
|
|||||
|
2022
Q1 | $28.9M | Buy |
|
|||||
|
2021
Q4 | $24.4M | Buy |
|
|||||
|
2021
Q3 | $20.9M | Buy |
|
|||||
|
2021
Q2 | $24.4M | Buy |
|
|||||
|
2021
Q1 | $16.8M | Buy |
|
|||||
|
2020
Q4 | $7.5M | Buy |
|